36
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Critical issues for engineering cord blood stem cells to produce insulin

&
Pages 1251-1254 | Published online: 11 Aug 2008

Bibliography

  • Harris DT, Rogers I. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007;2:301-9
  • Pipes BL, Tsang T, Peng SX, et al. Telomere length changes after umbilical cord blood transplant. Transfusion 2006;46:1038-43
  • Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:389-1394
  • Segev H, Fishman B, Ziskind A, et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 2004;22:265-74
  • Shi Y, Hou L, Tang F, et al. Inducing embryonic stem cells to differentiate into pancreatic β cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells 2005;23:656-62
  • Stafford D, Prince VE. Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development. Curr Biol 2002;12:1215-20
  • Hansson M, Tonning A, Frandsen U, et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 2004;53:2603-9
  • Rajagopal J, Anderson WJ, Kume S, et al. Insulin staining of ES cell progeny from insulin uptake. Science 2003;299:363
  • Bonner-Weir S. Stem cells in diabetes: what has been achieved. Horm Res 2003;60(Suppl 3):10
  • Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet 2004;364:203-5
  • Kodama S, Faustman DL. Routes to regenerating islet cells: stem cells and other biological therapies for type 1 diabetes. Pediatr Diabetes 2004;5(Suppl 2):38-44
  • Lechner A. Stem cells and regenerative medicine for the treatment of type 1 diabetes: the challenges lying ahead. Pediatr Diabetes 2004;5(Suppl 2):88-93
  • Roche E, Enseat-Wase R, Reig JA, et al. Therapeutic potential of stem cells in diabetes. Handb Exp Pharmacol 2006;147-67
  • Street CN, Rajotte RV, Korbutt GS. Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes. Curr Top Dev Biol 2003;58:111-36
  • Yamada S, Kojima I. Regenerative medicine of the pancreatic β cells. J Hepatobiliary Pancreat Surg 2005;12:218-26
  • Booth HA, Holland PW. Eleven daughters of NANOG. Genomics 2004;84:229-38
  • Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41-6
  • Gao R, Ustinov J, Pulkkinen MA, et al. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes 2003;52:2007-15
  • Seaberg RM, Smukler SR, Kieffer TJ, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004;22:1115-24
  • Weir GC, Bonner-Weir S. β-cell precursors–a work in progress. Nat Biotechnol 2004;22:1095-6
  • Burke ZD, Tosh D. Therapeutic potential of transdifferentiated cells. Clin Sci (Lond) 2005;108:309-21
  • Di Gioacchino G, Di Campli C, Zocco MA, et al. Transdifferentiation of stem cells in pancreatic cells: state of the art. Transplant Proc 2005;37:2662-3
  • Yalniz M, Pour PM. Are there any stem cells in the pancreas? Pancreas 2005;31:108-18
  • Bock T. The source(s) for new pancreatic beta cells in adult life. Bioessays 2004;26:1156-9
  • Choi Y, Ta M, Atouf F, Lumelsky N. Adult pancreas generates multipotent stem cells and pancreatic and nonpancreatic progeny. Stem Cells 2004;22:1070-84
  • Habener JF. A perspective on pancreatic stem/progenitor cells. Pediatr Diabetes 2004;5(Suppl 2):29-37
  • Hayek A. In search of endocrine progenitor/stem cells in the human pancreas. Pediatr Diabetes 2004;5(Suppl 2):70-4
  • Brolen GK, Heins N, Edsbagge J, Semb H. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing β-cell-like cells. Diabetes 2005;54:2867-74
  • Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342:1846-54
  • Rubinstein P, Adamson JW, Stevens C. The Placental/Umbilical Cord Blood Program of the New York Blood Center. A progress report. Ann NY Acad Sci 1999;872:328-34; discussion 334-25
  • Cohen Y, Nagler A. Umbilical cord blood transplantation–how, when and for whom? Blood Rev 2004;18:167-79
  • Liu E, Law HK, Lau YL. Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. Br J Haematol 2004;126:517-26
  • Harris DT. Experience in autologous and allogeneic cord blood banking. J Hematother 1996;5:123-8
  • Forraz N, Pettengell R, Deglesne PA, McGuckin CP. AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br J Haematol 2002;119:516-24
  • McGuckin CP, Forraz N, Allouard Q, Pettengell R. Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp Cell Res 2004;295:350-9
  • McGuckin CP, Forraz N, Baradez MO, et al. Colocalization analysis of sialomucins CD34 and CD164. Stem Cells 2003;21:162-70
  • McGuckin CP, Pearce D, Forraz N, et al. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol 2003;71:341-50
  • Forraz N, Pettengell R, McGuckin CP. Haemopoietic and neuroglial progenitors are promoted during cord blood ex vivo expansion. Br J Haematol 2002;119:888
  • McGuckin CP, Forraz N, Pettengell R, Thompson A. Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif 2004;37:295-306
  • Giannoukakis N, Robbins PD. Gene and cell therapies for diabetes mellitus: strategies and clinical potential. BioDrugs 2002;16:149-73
  • Kato Y, Tsunoda Y. Totipotency and pluripotency of embryonic nuclei in the mouse. Mol Reprod Dev 1993;36:276-8
  • Denner L, Bodenburg Y, Zhao JG, et al. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif 2007;40:367-80
  • McGuckin CP, Forraz N, Baradez MO, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 2005;38:245-55
  • Zhao Y, Wang H, Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 2006;312:2454-64
  • Howe M, Zhao J, Bodenburg Y, et al. Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny. Cell Proliferation 2008 (In Press)
  • He X, Gonzalez V, Tsang A, et al. Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells. Stem Cells Dev 2005;14:188-98

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.